Denali Therapeutics Inc.·4

Jan 8, 8:25 PM ET

Schuth Alexander O. 4

4 · Denali Therapeutics Inc. · Filed Jan 8, 2025

Insider Transaction Report

Form 4
Period: 2025-01-06
Schuth Alexander O.
COFO and Secretary
Transactions
  • Sale

    Common Stock

    2025-01-06$20.22/sh12,255$247,796247,215 total
  • Sale

    Common Stock

    2025-01-07$20.81/sh2,907$60,495244,308 total
Holdings
  • Common Stock

    (indirect: See footnote)
    523,749
Footnotes (4)
  • [F1]Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
  • [F2]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.91 to $20.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  • [F3]Includes 134,030 Unvested RSUs.
  • [F4]The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Documents

1 file
  • 4
    wk-form4_1736385937.xmlPrimary

    FORM 4